These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38067360)

  • 1. Potential of Fecal Carcinoembryonic Antigen for Noninvasive Detection of Colorectal Cancer: A Systematic Review.
    Li X; Stassen L; Schrotz-King P; Zhao Z; Cardoso R; Raut JR; Bhardwaj M; Brenner H
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage.
    Li L; Xing S; Wu M; Ao Y; Zheng X; Cai R; Han R; Li J; Li X; Zeng Q
    Cancer Control; 2021; 28():10732748211048292. PubMed ID: 34615391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of fecal carcinoembryonic antigen as diagnosis marker for adenomatous polyposis coli and asymptomatic colorectal cancer.
    Li L; Gu W; Wu X; Ao Y; Song Y; Li X; Zeng Q
    Therap Adv Gastroenterol; 2021; 14():17562848211062792. PubMed ID: 34987605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating CEA-IgM complexes in early stage colorectal cancer.
    Castaldi F; Marino M; Beneduce L; Belluco C; De Marchi F; Mammano E; Nitti D; Lise M; Fassina G
    Int J Biol Markers; 2005; 20(4):204-8. PubMed ID: 16398401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review.
    Raut JR; Guan Z; Schrotz-King P; Brenner H
    Clin Epigenetics; 2020 Aug; 12(1):122. PubMed ID: 32778176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of carcinoembryonic antigen detection in the early diagnosis of colorectal cancer: A systematic review and meta-analysis.
    Wang R; Wang Q; Li P
    World J Gastrointest Surg; 2023 Dec; 15(12):2907-2918. PubMed ID: 38222002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stool
    Zhan Y; Wang S; Yuan Z; Zhao X; Ni K; Xin R; Zhou X; Liu Z; Yin X; Ping H; Liu Y; Wang W; Yan S; Han Q; Zhang X; Zhang Q; Liu Y; Zhang C
    Transl Cancer Res; 2023 Jan; 12(1):65-77. PubMed ID: 36760372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved diagnosis of colorectal cancer using combined biomarkers including Fusobacterium nucleatum, fecal occult blood, transferrin, CEA, CA19-9, gender, and age.
    Zhao R; Xia D; Chen Y; Kai Z; Ruan F; Xia C; Gong J; Wu J; Wang X
    Cancer Med; 2023 Jul; 12(13):14636-14645. PubMed ID: 37162269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
    Meklin J; SyrjÄnen K; Eskelinen M
    Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte immunoglobulin-like receptor B2 overexpression as a promising therapeutic target and noninvasive screening biomarker for colorectal cancer.
    Wang QQ; Zhou L; Qin G; Tan C; Zhou YC; Yao SK
    World J Gastroenterol; 2023 Oct; 29(37):5313-5326. PubMed ID: 37899785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer.
    Huang X; Lan Y; Li E; Li J; Deng Q; Deng X
    J Int Med Res; 2021 May; 49(5):3000605211012570. PubMed ID: 33942633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: A systematic review and meta-analysis.
    Zhang X; Zhu X; Cao Y; Fang JY; Hong J; Chen H
    Cancer Med; 2019 Feb; 8(2):480-491. PubMed ID: 30636375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal microRNAs, Fecal microRNA Panels, or Combinations of Fecal microRNAs with Fecal Hemoglobin for Early Detection of Colorectal Cancer and Its Precursors: A Systematic Review.
    Zhao Z; Zhu A; Bhardwaj M; Schrotz-King P; Brenner H
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples.
    Thomas DS; Fourkala EO; Apostolidou S; Gunu R; Ryan A; Jacobs I; Menon U; Alderton W; Gentry-Maharaj A; Timms JF
    Br J Cancer; 2015 Jul; 113(2):268-74. PubMed ID: 26035703
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.